Exploring Treatment Options Through Genomic Sequencing in Endometrial Cancer
Risk factors and biomarker testing in conjunction with cancer staging may better identify ideal treatment for endometrial cancer than cancer staging alone.
Managing Risks, Planning Treatment, & Making Progress in Pancreatic Cancer
A nurse practitioner discussed risk factors, diagnostic challenges, and treatment planning in patients with pancreatic cancers.
Durvalumab Does Not Improve Outcomes Vs Cetuximab in Head and Neck Cancer
For patients with head and neck squamous cell carcinoma and contraindications to cisplatin, durvalumab yielded worse PFS vs cetuximab.
Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer
Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.
Vorasidenib Improves PFS, Shows Tumor Reduction in IDH1/2+ Glioma
Treatment with vorasidenib also confers better seizure control than placebo in the phase 3 INDIGO study.
ASTRO Guideline Recommends EBRT for Symptomatic Bone Metastases
ASTRO assembled a task force to create a guideline for the administration of palliative external beam radiation therapy for patients with symptomatic bone metastases.
